International Max Planck Research School for Translational Psychiatry (IMPRS-TP)

The IMPRS-TP is comprised of faculty members from:

Max Planck Institute of Psychiatry
Max Planck Institute of Neurobiology
Department of Psychiatry and Psychotherapy, LMU Munich
Center for Neuropathology and Prion Research, LMU Munich
Institute of Psychiatric Phenomics and Genomics, LMU Munich
Department of Neuroanatomy, LMU Munich
Institute of Psychiatry, King's College London, UK

We have established many international collaborations, for example with:

Weizmann Institute of Science, Israel
Biomedicine Research Institute of Buenos Aires – CONICET, Argentina
Kerry Ressler, McClean Hospital at Harvard University, USA

Successful research in clinically-oriented neuroscience and psychiatry needs to bridge findings from the molecular to the systems level and integrate basic science and clinical knowledge.

IMPRS-TP’s research aim is the translation of basic and clinical research into practical solutions for improved diagnosis and treatment of people affected by psychiatric disorders such as depression, schizophrenia, mood and anxiety disorders.

We provide interdisciplinary training in molecular, cellular and systemic psychiatric research to outstanding doctoral students in an environment of scientific excellence and collaboration to foster translational research. During the course of their studies, students are exposed to a wide range of scientific questions and methods covering areas of molecular medicine, neuroscience, psychiatry, neuroimaging, design-based stereology and clinical studies.

In addition to traditional PhD positions, we offer a unique integrated PhD/residence program in psychiatry for medical doctors. Highlighting the translational facet, PhD students receive insights into clinical aspects of disease and young medical doctors gain research expertise while also developing their clinical skills.

 
loading content